Synchrony Financial filings document the regulatory record of a consumer finance company with common stock and preferred depositary shares listed on the New York Stock Exchange. Its Form 8-K reports include quarterly earnings releases, financial data supplements, presentations and monthly charge-off and delinquency statistics tied to the company’s credit portfolio.
The company’s proxy materials cover annual meeting matters, director elections, auditor ratification and advisory executive compensation votes. Other filings describe capital-structure activity, including public debt offerings under shelf registration statements, senior note indenture terms, preferred stock series and related exhibits.
Synchrony Financial director reports stock grant
A director of Synchrony Financial reported acquiring 660 shares of common stock on December 31, 2025 at a price of $83.43 per share, as shown in a Form 4 filing. Following this transaction, the director beneficially owns 50,411 shares of Synchrony Financial common stock in direct ownership.
The filing explains that this grant represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of Synchrony Financial common stock at vesting. This reflects routine equity-based compensation rather than an open-market purchase or sale.
Synchrony Financial director reports stock-based award and holdings
A Synchrony Financial director reported receiving 660 shares of common stock as a stock-based award on 12/31/2025 at a price of $83.43 per share. These are in the form of restricted stock units that will vest in full on December 31, 2026, with each unit representing a contingent right to receive one share of Synchrony Financial common stock.
Following this grant, the director beneficially owns 38,734 shares directly and 34,106 shares indirectly through Guthrie 2012 Investments LP, where he is the investment manager and disclaims beneficial ownership except for his direct pecuniary interest.
Synchrony Financial reported an equity award to one of its directors. On December 31, 2025, the director acquired 1,035 shares of Synchrony Financial common stock at a price of $83.43 per share, recorded as an acquisition of non-derivative securities. After this transaction, the director beneficially owned 62,487 shares of Synchrony Financial common stock in direct form.
The filing explains that this grant represents restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit gives the director a contingent right to receive one share of Synchrony Financial common stock once the vesting date is reached, aligning director compensation with the company’s share performance.
Synchrony Financial director reports stock-based compensation grant. A board member of Synchrony Financial received 660 shares of common stock on December 31, 2025 at a price of $83.43 per share, reported as an acquisition of non-derivative securities. Following this transaction, the director beneficially owns 36,444 shares of Synchrony Financial common stock in direct ownership.
The grant represents restricted stock units that will vest in full on December 31, 2026, with each unit convertible into one share of Synchrony Financial common stock. This filing reflects routine equity compensation for a director rather than an open-market purchase or sale.
Synchrony Financial reported that one of its directors acquired additional equity through a stock-based award. On December 31, 2025, the director received 660 shares of common stock, shown at a price of $83.43 per share, bringing the director’s directly held beneficial ownership to 30,529 shares after the transaction.
An explanation clarifies that this award represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of Synchrony Financial common stock when vested. This filing reflects routine director compensation in the form of equity rather than an open-market purchase or sale.
Synchrony Financial filed a current report announcing that it is providing investors with updated credit quality information. The company is furnishing, as Exhibit 99.1, its Monthly Charge-Off and Delinquency Statistics for each of the thirteen months ended November 30, 2025, giving a view of recent trends in loan performance and customer payment behavior.
Synchrony states that it plans to continue furnishing these statistics every month. For the final month of each calendar quarter, the data will be released at the same time as the company’s quarterly financial results, helping readers see how credit metrics and overall performance align. The company also clarifies that this information is being “furnished” under a disclosure item rather than “filed,” which affects how it is treated under securities law.
Synchrony Financial (SYF) reported an insider equity accrual for its EVP and CFO on a Form 4. On 11/17/2025, the officer received 294 dividend equivalent units tied to restricted stock units, reflecting dividends paid on the underlying common shares at a reference price of $70.47 per unit. These dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is economically equal to one share of Synchrony Financial common stock.
After this transaction, the reporting person beneficially owned 69,170 common shares or related units on a direct basis.
Synchrony Financial filed a Form 4 reporting a routine equity-related transaction by an officer who serves as SVP, Chief Accounting Officer and Controller. On 11/17/2025, the officer received 61 dividend equivalent units at a value of $70.47 per unit, credited as dividends on common shares underlying restricted stock units. After this transaction, the officer beneficially owned 17,935 non-derivative securities directly. The dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is the economic equivalent of one share of Synchrony Financial common stock.
Synchrony Financial (SYF) reported a Form 4 filing showing a director acquired additional equity-linked units through routine compensation. On November 17, 2025, the director received 15 dividend equivalent units tied to previously granted restricted stock units, at a reference price of $70.47 per unit. These dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is the economic equivalent of one share of Synchrony Financial common stock. Following this transaction, the director beneficially owns 32,115 common shares on a direct basis.
Synchrony Financial (SYF) executive reports dividend-related equity awards. On 11/17/2025, an officer serving as EVP, CEO–Health & Wellness reported receiving 213 dividend equivalent units at a reference price of $70.47 per unit, tied to restricted stock units in Synchrony common stock. Following this, the officer beneficially owned 57,130 shares of common stock directly.
The filing also shows acquisition of 0.78 phantom stock units under the Synchrony Financial Deferred Compensation Plan, increasing total phantom stock units beneficially owned to 184.13. Both the dividend equivalent units and phantom stock units are described as economically equivalent to shares of Synchrony common stock, with the phantom units to be settled in cash six months after the officer’s separation from service, in line with plan terms.